Trials / Completed
CompletedNCT03089359
Prehospital Recognition and Identification of Unspecific Symptoms
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 414 (actual)
- Sponsor
- Karolinska Institutet · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study evaluates the predictive value of soluvent urokinase plasminogen activator receptor (suPAR) and lactate with respect to serious conditions among patients presenting to the EMS with unspecific symptoms.
Conditions
Timeline
- Start date
- 2015-05-04
- Primary completion
- 2021-03-23
- Completion
- 2021-03-23
- First posted
- 2017-03-24
- Last updated
- 2021-03-25
Locations
2 sites across 2 countries: Finland, Sweden
Source: ClinicalTrials.gov record NCT03089359. Inclusion in this directory is not an endorsement.